These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function. Langley WA, Thoennes S, Bradley KC, Galloway SE, Talekar GR, Cummings SF, Varecková E, Russell RJ, Steinhauer DA. Virology; 2009 Nov 25; 394(2):321-30. PubMed ID: 19755201 [Abstract] [Full Text] [Related]
4. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores. Melikyan GB, Jin H, Lamb RA, Cohen FS. Virology; 1997 Aug 18; 235(1):118-28. PubMed ID: 9300043 [Abstract] [Full Text] [Related]
5. Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Kretzschmar E, Bui M, Rose JK. Virology; 1996 Jun 01; 220(1):37-45. PubMed ID: 8659126 [Abstract] [Full Text] [Related]
7. Molecular view of the role of fusion peptides in promoting positive membrane curvature. Fuhrmans M, Marrink SJ. J Am Chem Soc; 2012 Jan 25; 134(3):1543-52. PubMed ID: 22191854 [Abstract] [Full Text] [Related]
13. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus. Varecková E, Wharton SA, Mucha V, Gocník M, Kostolanský F. Acta Virol; 2003 Jan 25; 47(4):229-36. PubMed ID: 15068378 [Abstract] [Full Text] [Related]
14. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics. Su Y, Zhu X, Wang Y, Wu M, Tien P. Arch Virol; 2008 Jan 25; 153(2):247-57. PubMed ID: 18030546 [Abstract] [Full Text] [Related]
15. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor. Bianchi E, Liang X, Ingallinella P, Finotto M, Chastain MA, Fan J, Fu TM, Song HC, Horton MS, Freed DC, Manger W, Wen E, Shi L, Ionescu R, Price C, Wenger M, Emini EA, Cortese R, Ciliberto G, Shiver JW, Pessi A. J Virol; 2005 Jun 25; 79(12):7380-8. PubMed ID: 15919893 [Abstract] [Full Text] [Related]
18. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid. Staschke KA, Hatch SD, Tang JC, Hornback WJ, Munroe JE, Colacino JM, Muesing MA. Virology; 1998 Sep 01; 248(2):264-74. PubMed ID: 9721235 [Abstract] [Full Text] [Related]
19. Adaptation of egg-grown and transfectant influenza viruses for growth in mammalian cells: selection of hemagglutinin mutants with elevated pH of membrane fusion. Lin YP, Wharton SA, Martín J, Skehel JJ, Wiley DC, Steinhauer DA. Virology; 1997 Jul 07; 233(2):402-10. PubMed ID: 9217063 [Abstract] [Full Text] [Related]
20. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions. Zhou Y, König M, Hobom G, Neumeier E. Virology; 1998 Jun 20; 246(1):83-94. PubMed ID: 9656996 [Abstract] [Full Text] [Related] Page: [Next] [New Search]